Patents by Inventor Sima Yaron

Sima Yaron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7635685
    Abstract: A novel group of aminoglycosides which share some structural features of currently available aminoglycosides with regard to the backbone, while also having significant structural differences, is disclosed. The similarity enables these aminoglycosides to be highly potent and effective antibiotics, while the significant differences enable these aminoglycosides to reduce or even block antibiotic resistance. The aminoglycosides of the present invention are suitable for inhibition of antrax lethal factor, hence are suitable for use as a cure for anthrax.
    Type: Grant
    Filed: March 8, 2005
    Date of Patent: December 22, 2009
    Assignee: Technion Research & Development Foundation Ltd.
    Inventors: Timor Baasov, Micha Fridman, Valery Belakhov, Sima Yaron
  • Publication number: 20050148522
    Abstract: A novel group of aminoglycosides which share some structural features of currently available aminoglycosides with regard to the backbone, while also having significant structural differences, is disclosed. The similarity enables these aminoglycosides to be highly potent and effective antibiotics, while the significant differences enable these aminoglycosides to reduce or even block antibiotic resistance. The aminoglycosides of the present invention are suitable for inhibition of antrax lethal factor, hence are suitable for use as a cure for anthrax.
    Type: Application
    Filed: March 8, 2005
    Publication date: July 7, 2005
    Inventors: Timor Baasov, Micha Fridman, Valery Belakhov, Sima Yaron
  • Publication number: 20050004052
    Abstract: A novel group of aminoglycosides which share some structural features of currently available aminoglycosides with regard to the backbone, while also having significant structural differences. The similarity enables these aminoglycosides to be highly potent and effective antibiotics, while the significant differences enable these aminoglycosides to reduce or even block antibiotic resistance.
    Type: Application
    Filed: April 23, 2004
    Publication date: January 6, 2005
    Inventors: Timor Baasov, Micha Fridman, Valery Belakhov, Sima Yaron